Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04802187 · ClinicalTrials.gov registry record · NA

Implementation of COVID-19 Testing Strategies in Community Health Centers

A NA study of COVID-19, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
6
Enrollment target
2
Study locations

NCT04802187: Completed NA study of COVID-19, sponsored by Massachusetts General Hospital.

NCT04802187 is a NA study of COVID-19 that has completed, run by Massachusetts General Hospital. The registered enrollment target is 6 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04802187, a NA study of COVID-19, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
2
Study locations

Study Summary

This project is part of a competitive revision to accelerate COVID-19 testing in underserved populations. The overall aim is to implement strategies to expand COVID testing in hotspot communities in MA, through 6 community health center (CHC)-community partnerships. A base strategy will be implemented at all sites. A tailored strategy unique to local populations will be added and tested in a stepped wedge design.

Primary Outcome

Acceleration of covid testing volume during covid surges, estimated as the percent change in weekly covid testing volume trend for each 10% increase in covid cases. A slope value was estimated from a segmented regression model for the entire study period, which was then used to calculate a difference between the post- and pre-implementation periods.

Conditions Studied

COVID-19

Interventions

  • OTHER RADx CHCs testing intervention strategy
  • OTHER Usual care control

Study Locations (2)

Massachusetts

  • Massachusetts League of Community Health Centers - Boston
  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2020-12-01
Est. Completion 2022-07-15
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT04802187 record still lists

NCT04802187 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which RADx CHCs testing intervention strategy is the first listed.

NCT04802187 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04802187 about?

NCT04802187 is a clinical study titled "Implementation of COVID-19 Testing Strategies in Community Health Centers". This project is part of a competitive revision to accelerate COVID-19 testing in underserved populations. The overall aim is to implement strategies to expand COVID testing in hotspot communities in MA, through 6 community health center (CHC)-community partnerships. A base strategy will be implement...

What is the current status of trial NCT04802187?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-12-01. Estimated completion is 2022-07-15.

What conditions does trial NCT04802187 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT04802187?

The interventions under investigation include: RADx CHCs testing intervention strategy (OTHER), Usual care control (OTHER).

Who is sponsoring clinical trial NCT04802187?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04802187 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04802187's enrollment target sits among peer trials

6 295th of 298 higher than 4 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04802187, the US trial registry maintained by the National Library of Medicine. NCT04802187 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.